Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Transcranial Direct Current Stimulation for Post Treatment Lyme Disease

NCT: NCT06915324 · RECRUITING

NCT IDNCT06915324
StatusRECRUITING
Start Date2025-07-14
Completion2027-08

Brief Summary

The primary purpose of this pilot study is to investigate a novel approach to the treatment of cognitive symptoms that persist despite prior antibiotic treatment for Lyme disease (Post treatment Lyme Disease or PTLD). Aim 1: The primary aim of this study is to assess whether the processing speed of individuals with PTLD can be enhanced by combining transcranial direct current stimulation (tDCS) with computer based cognitive training games. To achieve this aim, over a 4-week period, all individuals with PTLD will participate in at home adaptive cognitive training combined with either active stimulation or sham stimulation. Aim 2: To determine if treatment benefit in processing speed is sustained, the study will compare the sham and active groups 8 weeks after completion of study treatment.

Frequently Asked Questions

What is Transcranial Direct Current Stimulation for Post Treatment Lyme Disease?

Transcranial Direct Current Stimulation for Post Treatment Lyme Disease is a clinical trial registered under NCT06915324. Current status: RECRUITING.

What is the status of NCT06915324?

The current status of NCT06915324 (Transcranial Direct Current Stimulation for Post Treatment Lyme Disease) is: RECRUITING.

When did Transcranial Direct Current Stimulation for Post Treatment Lyme Disease start?

Transcranial Direct Current Stimulation for Post Treatment Lyme Disease started on 2025-07-14.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.